(Q37777156)

23 August 2017

1 reference

title

Treatment options for primary sclerosing cholangitis (English)

1 reference

primary sclerosing cholangitis

23 August 2017

main subject

ascending cholangitis

0 references

1 reference

1

Emmanouil Sinakos

1 reference

23 August 2017

Keith Lindor

2

1 reference

23 August 2017

publication date

1 August 2010

1 reference

Expert Review of Gastroenterology & Hepatology

23 August 2017

published in

1 reference

23 August 2017

volume

4

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

473-488

1 reference

Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology

23 August 2017

cites work

1 reference

Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community

21 January 2018

1 reference

Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver.

21 January 2018

1 reference

Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom

21 January 2018

1 reference

Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.

21 January 2018

1 reference

Primary Sclerosing Cholangitis, Inflammatory Bowel Disease, and Colon Cancer

21 January 2018

1 reference

Primary sclerosing cholangitis: summary of a workshop

21 January 2018

1 reference

Genome-wide association analysis in primary sclerosing cholangitis

21 January 2018

1 reference

EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

21 January 2018

1 reference

Diagnosis and management of primary sclerosing cholangitis.

21 January 2018

1 reference

Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study.

21 January 2018

1 reference

Sclerosing cholangitis: a focus on secondary causes

21 January 2018

1 reference

The natural history of small-duct primary sclerosing cholangitis

21 January 2018

1 reference

Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature

21 January 2018

1 reference

Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.

21 January 2018

1 reference

Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome

21 January 2018

1 reference

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

21 January 2018

1 reference

Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis

21 January 2018

1 reference

Primary sclerosing cholangitis in children: a long-term follow-up study

21 January 2018

1 reference

Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population

21 January 2018

1 reference

Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study.

21 January 2018

1 reference

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis

21 January 2018

1 reference

Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis

21 January 2018

1 reference

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis

21 January 2018

1 reference

Etiopathogenesis of primary sclerosing cholangitis

21 January 2018

1 reference

Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease.

21 January 2018

1 reference

Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study

21 January 2018

1 reference

Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis

21 January 2018

1 reference

Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study

21 January 2018

1 reference

Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis

21 January 2018

1 reference

Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression.

21 January 2018

1 reference

Bone mineral density before and after OLT: long-term follow-up and predictive factors.

21 January 2018

1 reference

Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.

21 January 2018

1 reference

In primary sclerosing cholangitis, gallbladder polyps are frequently malignant

21 January 2018

1 reference

Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis

21 January 2018

1 reference

Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis

21 January 2018

1 reference

Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis.

21 January 2018

1 reference

Early detection and treatment of cholangiocarcinoma

21 January 2018

1 reference

The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis

21 January 2018

1 reference

Elevated serum levels of tumor marker CA19-9 in acute cholangitis.

21 January 2018

1 reference

Markedly elevated serum CA 19-9 levels in association with a benign biliary stricture due to primary sclerosing cholangitis

21 January 2018

1 reference

Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures

21 January 2018

1 reference

Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis

21 January 2018

1 reference

Is there a role for cholangioscopy in patients with primary sclerosing cholangitis?

21 January 2018

1 reference

Colchicine treatment of primary sclerosing cholangitis

21 January 2018

1 reference

Pirfenidone in the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

A pilot study of etanercept in the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin

21 January 2018

1 reference

A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

Mycophenolate mofetil for the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial

21 January 2018

1 reference

Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic

21 January 2018

1 reference

Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study

21 January 2018

1 reference

Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.

21 January 2018

1 reference

High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective

21 January 2018

1 reference

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

21 January 2018

1 reference

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

21 January 2018

1 reference

High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study

21 January 2018

1 reference

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study

21 January 2018

1 reference

An open-label pilot trial of cladibrine (2-cholordeoxyadenosine) in patients with primary sclerosing cholangitis

21 January 2018

1 reference

Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot study

21 January 2018

1 reference

Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study

21 January 2018

1 reference

Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment

21 January 2018

1 reference

Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis

21 January 2018

1 reference

Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct

21 January 2018

1 reference

Primary sclerosing cholangitis: the role of endoscopic therapy

21 January 2018

1 reference

A twenty-year experience with endoscopic therapy for symptomatic primary sclerosing cholangitis

21 January 2018

1 reference

Primary sclerosing cholangitis treated by endoscopic biliary dilation: review and long-term follow-up evaluation

21 January 2018

1 reference

Four years experience with short term stenting in primary sclerosing cholangitis

21 January 2018

1 reference

The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis

21 January 2018

1 reference

Resection of Hepatic Duct Bifurcation and Transhepatic Stenting for Sclerosing Cholangitis

21 January 2018

1 reference

Primary sclerosing cholangitis: role of extrahepatic biliary resection

21 January 2018

1 reference

Surgical biliary drainage in primary sclerosing cholangitis. The role of the Hepp-Couinaud approach

21 January 2018

1 reference

Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list

21 January 2018

1 reference

Liver transplantation in primary sclerosing cholangitis

21 January 2018

1 reference

Ileal pouch-anal anastomosis and liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitis

21 January 2018

1 reference

Liver transplantation for cholangiocarcinoma: results in 207 patients

21 January 2018

1 reference

Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries

21 January 2018

1 reference

Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis

21 January 2018

1 reference

Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database.

21 January 2018

1 reference

Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience.

21 January 2018

1 reference

Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis

21 January 2018

1 reference

Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis

21 January 2018

1 reference

Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis

21 January 2018

1 reference

Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens

21 January 2018

1 reference

Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.

21 January 2018

1 reference

Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis

21 January 2018

1 reference

Recurrence of autoimmune liver disease after liver transplantation: a systematic review

21 January 2018

1 reference

Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation

21 January 2018

1 reference

Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation

21 January 2018

1 reference

The impact of disease recurrence on graft survival following liver transplantation: a single centre experience

21 January 2018

1 reference

Primary biliary cirrhosis

21 January 2018

1 reference

The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus

21 January 2018

1 reference

Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis.

21 January 2018

1 reference

Extracorporeal albumin dialysis: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis

21 January 2018

1 reference

Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis

21 January 2018

1 reference

Review article: the modern management of hepatic encephalopathy

21 January 2018

1 reference

Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.

21 January 2018

1 reference

Surgical management of ulcerative colitis in the presence of primary sclerosing cholangitis

21 January 2018

1 reference

Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease

21 January 2018

1 reference

The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis

21 January 2018

1 reference

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

21 January 2018

1 reference

Bone disorders in chronic liver disease

21 January 2018

1 reference

Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial

21 January 2018

1 reference

Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience

21 January 2018

1 reference

Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy

21 January 2018

1 reference

The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid.

21 January 2018

1 reference

Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation

21 January 2018

1 reference

Cholangiocarcinoma complicating primary sclerosing cholangitis

21 January 2018

1 reference

Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience.

21 January 2018

1 reference

Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma

21 January 2018

1 reference

Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.

21 January 2018

1 reference

Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis

21 January 2018

1 reference

Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms

21 January 2018

1 reference

Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways

21 January 2018

1 reference

Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice

21 January 2018

1 reference

Novel biotransformation and physiological properties of norursodeoxycholic acid in humans.

21 January 2018

1 reference

Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-)transcriptional modulators?

21 January 2018

1 reference

6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity.

21 January 2018

1 reference

The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis

21 January 2018

1 reference

Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis

21 January 2018

1 reference

High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: throwing the urso out with the bathwater?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EGH.10.33

1 reference

23 August 2017

1 reference